Sternal Closure Systems Market Assessment, By Product Type [Closure Devices, Bone Cement], By Material Type [Titanium, Stainless Steel, Polyetheretherketone], By Procedure [Median Sternotomy, Hemi Sternotomy, Bilateral Thoracosternotomy], By End-user [Hos

Sternal Closure Systems Market Assessment, By Product Type [Closure Devices, Bone Cement], By Material Type [Titanium, Stainless Steel, Polyetheretherketone], By Procedure [Median Sternotomy, Hemi Sternotomy, Bilateral Thoracosternotomy], By End-user [Hospitals, Ambulatory Surgical Centers], By Region, Opportunities and Forecast, 2017-2031F

Global sternal closure systems market is projected to witness a CAGR of 5.51% during the forecast period 2024-2031F, growing from USD 2.81 billion in 2023 to USD 4.32 billion in 2031F.

Sternal closure systems aid in the recovery of sternum, or middle bone of the chest, close after surgery, especially thoracic and cardiac procedures. The type of surgery, patient's health, surgeon's preference, and improvements in surgical procedures play a role in the selection of type of sternal closure system. To reduce the possibility of problems including mediastinitis (infection of the mediastinum), sternal dehiscence (separation of the sternal margins), and poor healing, surgeons work to ensure stable and secure sternal closure. For surgeries related to heart and thoracic operations, there has been a shift towards minimally invasive surgical methods. As a result, sternal closure systems have evolved to meet the needs of minimally invasive procedures. Specialized closure tools and methods that minimize surgical trauma and maximize sternal healing have been developed. Specialized closure systems that can handle smaller incisions and less tissue trauma are necessary for minimally invasive procedures, which encourages innovation and market acceptance. The need for sternal closure treatments and heart surgeries is rising due to aging global population.

The quality of service, surgical outcomes, and patient safety are becoming more important to healthcare providers. A secure sternal closure is necessary to reduce the possibility of problems post-surgery, which drives the market expansion. For instance, Abyrx Inc. received FDA certification for its moldable bone putty, MONTAGE, in September 2023. The product's approval covers its use in cardiothoracic surgery after a sternotomy. Heart surgeons can enhance sternal repair and closure with the use of MONTAGE.

Advancements in Surgical Techniques Lead to Market Expansion

The increasing use of minimally invasive techniques for a variety of thoracic and cardiac surgeries is a result of advancements in surgical techniques. Comparing minimally invasive techniques to open operations which are more complex, minimally invasive operations are more in demand due to fewer incisions and less tissue damage. Consequently, there is an increasing need for sternal closure devices, made especially to support these minimally invasive methods. Specialized sternal closure devices that are adaptable, simple to operate, and can provide a secure closure with the least amount of tissue stress are needed for minimally invasive surgical procedures. Innovative designs that provide improved stability and support throughout the healing process, including sutures, clips, or sternal plates, may be incorporated into these closure systems. There is a decreased chance of post-operative complications, such as mediastinitis and sternal dehiscence, with minimally invasive techniques. Secure sternal closure is crucial to avoid these issues and encourage the best possible healing after thoracic and cardiac procedures.

Improved patient outcomes result from both the adoption of specialized sternal closure methods and advances in surgical procedures. Comparing minimally invasive techniques to open operations, minimally invasive surgeries offer shorter hospital stays, quicker recovery periods, less pain following the surgery, and better cosmetic outcomes. These advantages improve patients' quality of life and level of satisfaction. Sternal closure methods with dependable performance and compatibility with minimally invasive approaches are preferred by surgeons. Surgeons are more confident during surgical procedures due to advanced closure methods that minimize the risk of problems and enable safe sternal closure. Technological progress propels innovation in sternal closure systems, creating novel materials, designs, and methodologies. As surgical needs and patient preferences change, manufacturers constantly invest in R&D to enhance the sternal closure systems' efficacy, safety, and use of the sternal closure systems. Sternal closure devices that facilitate minimally invasive operations are in greater demand as patients and healthcare professionals become more aware of their advantages. In response to consumer demand, manufacturers design customized closure systems that meet the needs of minimally invasive surgical procedures, supporting the market's growth.

Able Medical Devices Inc., a J.M. Longyear LLC subsidiary, introduced its innovative stainless-steel Valkyrie Looped Sternotomy Sutures in January 2023. Compared to traditional wire sutures, these sutures are specifically made for closing a patient's chest after open heart surgery, offering a stronger sternal closure. The Valkyrie sutures are available in 48mm and 55mm sizes and come in 14-inch length. They offer twice the surface area of single wires. Additionally, they can be fitted with three alternative needle designs to accommodate various surgical needs.

Aging Population to Drive the Market Growth

People are increasingly vulnerable to cardiovascular conditions such as congestive heart failure, valvular heart disease, and coronary artery disease as they get older. Surgical interventions, such as sternotomy and sternal closure in cardiac operations, are frequently necessary. Sternal closure systems are in high demand since cardiovascular illnesses are becoming more common among the elderly population. Surgery is often required to manage heart diseases that are more common in the elderly population. It increases the requirement for cardiac procedures that include sternal closure, such as coronary artery bypass grafting (CABG), valve replacement or repair, and aortic surgery.

The demand for sternal closure systems to support surgical operations is rising. Surgical cases may become more challenging due to various comorbidities and complicated medical histories that older patients frequently appear with. When it comes to sternal closure in elderly patients, surgeons may face difficulties such as diminished bone quality, decreased sternal integrity, and a higher chance of problems following surgery. Global life expectancy has increased due to the advancements in disease management, medical technology, and healthcare. People who live longer are more likely to experience age-related cardiovascular diseases that need to be surgically treated.

Cardiac procedures, including those which necessitate sternal closure, can extend life expectancy, reduce symptoms, and improve quality of life. The demand for sternal closure devices reflects the desire to maintain and enhance the quality of life of aging people through surgical treatments. Global healthcare systems need to invest in infrastructure, resources, and specialized care services to meet the demands of aging population. It involves accessibility to sternal closure devices which are specifically designed to address the needs of elderly patients undergoing heart surgery.

For instance, according to a report published by WHO in 2022, one in six individuals on the planet will be 60 years or older by 2030. At this point, there will be 1.4 billion people over the age of 60, up from 1 billion in 2020. The number of individuals in the world who are 60 years of age or older is expected to double (to 2.1 billion) by 2050. It is anticipated that between 2020 and 2050, the number of people 80 years of age or older will treble, reaching 426 million.

Increasing Dominance and Popularity of Wires

Due to low cost, convenience of use, rapidity, and relatively low risk of complications, sternal closure with wires has become popular. The sternal halves formed during the median sternotomy are secured using either interrupted or figure-of-eight wires in common closure techniques. However, all wire systems permit some sternal hail movement and separation under physiologic loads. Unless the sternotomy is technically flawed, most patients with healthy sternums have no issues with these small movements. By encouraging early callus production, they might potentially hasten the healing process of broken bones. The aging population, an increase in cardiac procedures, and an increase in product developments by major industry players are the reasons driving the category's growth.

For instance, in August 2022, a National Center for Biotechnology Information (NCBI) article stated that over 400,000 coronary artery bypass grafting procedures are carried out annually worldwide. Similarly, about 29,947 isolated procedures for coronary artery bypass grafting, 36,714 isolated procedures for cardiac valve replacements, and 750 implantations of assist devices were registered in Germany in 2021, according to an article released by the NCBI in August 2022. Therefore, it is anticipated that the growing number of heart surgeries, out of which sternal closure wires are frequently used, which will aid in the segment's expansion.

Conversely, the market is anticipated to rise because of increased use of sternal closure wires, which are highly effective in sternal closure procedures. For instance, the NCBI report from May 2022 states that most popular and commonly used sternal fixation method is stainless-steel cerclage wires. Therefore, during the projected period, the increasing use of wire products in the sternal closure is anticipated to propel the sectoral expansion.

North America to Dominate Sternal Closure System Market

Over the course of the projected period, North America is anticipated to hold most of the market share. The increasing number of open heart and coronary artery bypass grafting procedures and the sophisticated healthcare infrastructure are the factors anticipated to fuel the market growth in the region. For example, according to data released by Detroit Medical Center in 2022, almost 500,000 Americans got open heart surgery annually. Additionally, 17,291 open heart operations were performed in New Jersey in 2021, according to a data released by the state's Department of Health in August 2022.

Furthermore, it is anticipated that the growing elderly population in North American nations, who are more likely to experience cardiac problems and require cardiac procedures, will increase demand for sternal closure devices and spur the market expansion. According to UCAM data from 2022, about 12% of Mexicans are 60 years of age or older. Therefore, during the projection period, the region's aging population is anticipated to fuel the market expansion.

Future Market Scenario (2024 – 2031F)

One of the main factors contributing to the anticipated growth of the global sternal closure systems market is the increasing prevalence of cardiovascular and thoracic disorders and the increasing popularity of minimally invasive surgical procedures. A rising population and sedentary lifestyles are factors which are expected to propel the market growth in the forecast period. As technology advances, we can expect innovative technology. Players in the market are expanding at an unparalleled rate, introducing cost-effective and efficient technologies. For instance, In May 2022 Granulab (M) Sdn. Bhd., a 70%-owned subsidiary of KPower Bhd., launched Prosteomax, a synthetic bone cement that is halal certified. The Malaysian Islamic Development Department validated Prosteomax as halal and registered it with the Malaysian Medical Device Authority for orthopaedics, cranial, dental, and maxillofacial applications.

Key Players Landscape and Outlook

Several companies like Medical Device Business Services, Inc. (DePuy Synthes), Zimmer Biomet Holdings Inc., B. Braun Medical Ltd., KLS Martin SE & Co. KG., Stryker Corporation, Teleflex Incorporated, Acumed LLC, Able Medical Devices Inc., Kinamed Inc., and Abyrx Inc., are expanding business by planning and adopting new strategies. They are complying with new strategic initiatives regarding the launches of newly developed sternal closure systems to help researchers and increase their presence in the market. New product launches, agreements based on contracts, acquisitions and mergers, investments, and partnerships are a few ways the players try to achieve the market size.

In February 2022, CircumFix Solutions Inc., a start-up company in Tennessee, obtained funding from Evonik Venture Capital. The company has created a revolutionary sternal closure device that aids in patients' recuperation after open chest surgery.